CIK 0001367083
- Non-accelerated filer
- Smaller reporting company
Sonoma Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SNOA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680423298
- Phone
- +1 800-759-9305
- Business address
- 5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
- Former names
- Oculus Innovative Sciences, Inc.
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $4.86 ($24,300)
- 4 Open-market buy Chief Executive Officer bought 1,000 shares at $4.88 ($4,880)
- 4 Grant or award Chief Executive Officer acquired 3,535 shares (grant or award)
- 4 Grant or award Exec. VP of Res & Devlpment acquired 4,678 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 15,593 shares (grant or award)
- 4 Grant or award Director acquired 1,423 shares (grant or award)
- 4 Grant or award Director acquired 1,229 shares (grant or award)
- 4 Grant or award Director acquired 841 shares (grant or award)
- 4 Grant or award Director acquired 1,035 shares (grant or award)
- 4 Grant or award Director acquired 1,648 shares (grant or award)
- 4 Grant or award Director acquired 1,423 shares (grant or award)
- 4 Grant or award Director acquired 974 shares (grant or award)
- 4 Grant or award Director acquired 1,199 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 1,328 shares at $3.66 ($4,866)
- 4 Grant or award Director acquired 6,765 shares (grant or award)
- 4 Grant or award Director acquired 5,090 shares (grant or award)
- 4 Grant or award Director acquired 4,188 shares (grant or award)
- 4 Grant or award Director acquired 4,445 shares (grant or award)
- 4 Grant or award Director acquired 17,878 shares (grant or award)
- 4 Grant or award Director acquired 16,237 shares (grant or award)
Page 7 of 16 · 317 filings